BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11737697)

  • 1. Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream.
    Schaen L; Mercurio MG
    Pediatr Dermatol; 2001; 18(5):450-2. PubMed ID: 11737697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod: a review.
    Gupta AK; Browne M; Bluhm R
    J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
    Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
    J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream.
    Moresi JM; Herbert CR; Cohen BA
    Pediatr Dermatol; 2001; 18(5):448-50; discussion 452. PubMed ID: 11737696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
    Vexiau D; Decuypère L; Moyse D; Aractingi S
    Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod: a cytokine inducer.
    Dahl MV
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
    Cox JT
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():51-4. PubMed ID: 14616817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of perianal warts in a child with 5% imiquimod cream.
    Gruber PC; Wilkinson J
    J Dermatolog Treat; 2001 Dec; 12(4):215-7. PubMed ID: 12241631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
    Carrasco D; vander Straten M; Tyring SK
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
    Hengge UR; Cusini M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod as an immune response modulator in infectious conditions.
    Skinner RB
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical imiquimod.
    Pearson GW; Langley RG
    J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata.
    Dede M; Kubar A; Yenen MC; Alanbay I; Guven S; Mesten Z; Baser I
    Acta Obstet Gynecol Scand; 2007; 86(8):968-72. PubMed ID: 17653883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod; an international update on therapeutic uses in dermatology.
    Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
    Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiqimod in clinical practice.
    Trofatter KF
    Eur J Dermatol; 1998; 8(7 Suppl):17-9; discussion 20-2. PubMed ID: 10387959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of imiquimod indirect antiviral activity].
    Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
    Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
    Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.